Enamines
Medchemexpress LLC Nimodipine | 66085-59-4 | 99.9% | 1 ML
Nimodipine is an orally active, well-tolerated, and light-sensitive dihydropyridine calcium antagonist. It is primarily used for the research of cerebrovascular disorders and is intended for research use only.
- Orally active and well-tolerated
- Light-sensitive dihydropyridine calcium antagonist
- Used in research for cerebrovascular disorders
- Available as a light yellow to yellow solid
- For research use only
![Medchemexpress LLC Benzamide, n-hydroxy-3-[1-[(phenylthio)methyl]-1h-1,2,3-triazol-4-yl]- | 1316652-41-1 | MFCD21363002 | 99.3% | 326.37 g/mol | C16H14N4O2S | 10 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000227030.png-250.jpg)
Medchemexpress LLC Benzamide, n-hydroxy-3-[1-[(phenylthio)methyl]-1h-1,2,3-triazol-4-yl]- | 1316652-41-1 | MFCD21363002 | 99.3% | 326.37 g/mol | C16H14N4O2S | 10 MG
NCC-149 is a selective histone deacetylase 8 (HDAC8) inhibitor used in neural differentiation research. It is a small-molecule benzamide derivative (C16H14N4O2S; MW 326.37 g/mol; CAS 1316652-41-1) supplied as a solid with documented purity and batch COA.
- Selective HDAC8 inhibitor useful for neural differentiation studies.
- Batch-specific purity reported at 99.3% (COA).
- Available as a small 10 MG solid suitable for research-scale experiments.
- Solid stable at -20°C for up to 3 years; solvent solutions require colder storage.
- Comes with COA, SDS, and product datasheet for quality and safety information.
eMolecules 354824-17-2 | 5-(Aminomethyl)-N,N-dimethylpyridin-2-amine | Combi-Blocks | MFCD08272104 | 151.213 | C8H13N3 | 98.000 | CN(C)c1ccc(CN)cn1 | 1g | 117575175
5-(Aminomethyl)-N,N-dimethylpyridin-2-amine | Combi-Blocks | 354824-17-2 | MFCD08272104 | 151.213 | C8H13N3 | 98.000 | CN(C)c1ccc(CN)cn1 | 1g | 117575175
Apexbio Technology LLC Mesoridazine Besylate 32672-69-8 50mg
Mesoridazine besylate (CAS 32672-69-8) is a phenothiazine derivative that functions primarily as a dopamine receptor antagonist demonstrating notable inhibitory activity against dopamine D2 and D4 receptors The molecule has particularly high affinity toward the dopamine D4 receptor subtype By modulating dopamine receptor activity Mesoridazine besylate has potential relevance in neuroscience research aimed at understanding dopamine-mediated neurological pathways and disorders Frequently utilized in studies of psychotic conditions the compound serves as an important tool for investigating receptor-specific pharmacological mechanisms
eMolecules 14205-39-1 | METHYL 3-AMINOCROTONATE | AstaTech | MFCD00071534 | 115.132 | C5H9NO2 | 97.000 | COC(=O)\C=C(\C)N | 25g | 482916541
METHYL 3-AMINOCROTONATE | AstaTech | 14205-39-1 | MFCD00071534 | 115.132 | C5H9NO2 | 97.000 | COC(=O)\C=C(\C)N | 25g | 482916541
Apexbio Technology LLC Cisatracurium Besylate 96946-42-8 10mM (in 1mL DMSO)
Cisatracurium Besylate (CAS 96946-42-8) is a non-depolarizing neuromuscular blocking agent that acts by competitively inhibiting acetylcholine at nicotinic receptors on the neuromuscular junction This inhibition prevents depolarization of the muscle cell membrane resulting in skeletal muscle relaxation Cisatracurium Besylate is utilized in biomedical research to study neuromuscular transmission skeletal muscle function and mechanisms underlying muscle paralysis It is also frequently used as an adjunct in anesthesia research to model conditions requiring controlled muscle relaxation such as intubation or mechanical ventilation
Medchemexpress LLC PF-562271 besylate | 939791-38-5 | MFCD14105612 | 99.2% | 665.66 g/mol | C27H26F3N7O6S2 | 1 ML
PF-562271 besylate is a potent, ATP-competitive, reversible inhibitor of focal adhesion kinase (FAK) and Pyk2 used in biochemical, cell-based, and in vivo research. It is supplied as a 10 mM solution in DMSO and exhibits low-nanomolar activity against FAK and nanomolar activity against Pyk2.
- Potent inhibition of FAK and Pyk2 (FAK IC50 = 1.5 nM; Pyk2 IC50 = 13 nM).
- Supplied as a ready-to-use 10 mM solution in DMSO for in vitro assays.
- High reported purity suitable for research use (99.17%).
- Demonstrated antiproliferative activity across multiple cancer cell lines.
- Validated pharmacological effects in vivo, including inhibition of FAK phosphorylation.
Medchemexpress LLC Amlodipine benzenesulfonate | 111470-99-6 | 99.7% | 500 MG
Amlodipine besylate (Amlodipine benzenesulfonate) is an orally active dihydropyridine calcium channel blocker and antianginal agent. It functions by blocking voltage-dependent L-type calcium channels, inhibiting initial calcium influx. This compound can be used for research into high blood pressure and cancer.
- Blocks voltage-dependent L-type calcium channels
- Inhibits initial influx of calcium
- Useful for high blood pressure research
- Useful for cancer research
Medchemexpress LLC Amlodipine besylate | 111470-99-6 | 99.7% | 1 ML
Amlodipine besylate is an antianginal agent and an orally active dihydropyridine calcium channel blocker. It functions by blocking voltage-dependent L-type calcium channels, which inhibits the initial influx of calcium. This product is for research use only and not sold to patients.
- Used for high blood pressure and cancer research
- Inhibits initial influx of calcium by blocking L-type channels
- Available as 10 mM in 1 mL solution in DMSO
Medchemexpress LLC Methyl but-3-enoate 25g
Methyl but-3-enoate is a drug intermediate for synthesis of various active compounds
Apexbio Technology LLC Amlodipine 88150-42-9 1g
Amlodipine (CAS 88150-42-9) is a dihydropyridine-based small molecule that functions as a long-acting calcium channel blocker It selectively inhibits L-type calcium channels on vascular smooth muscle and cardiac myocytes thereby reducing intracellular calcium influx This action leads to vasodilation and decreased vascular resistance Amlodipine is widely utilized in biomedical research to investigate calcium signaling pathways vascular tone modulation and cardiovascular pharmacology Its mechanistic profile also makes it a reference compound in studies evaluating novel antihypertensive or vasodilatory agents
Medchemexpress LLC (R)-Nimodipine ((R)-BAY-e 9736) | 77940-92-2 | 99.9% | 5 MG
(R)-Nimodipine ((R)-BAY-e 9736) | 77940-92-2 | 99.9% | 5 MG
Medchemexpress LLC (R)-Nimodipine | 77940-92-2 | 99.9% | 50 MG
(R)-Nimodipine is an orally active, blood-brain barrier-permeable L-type calcium channel blocker with an IC50 of 5 nM. It inhibits corticosterone release by blocking calcium channels on the hypothalamic-pituitary-adrenal axis, which can reverse immobilization stress-induced memory impairment and behavioral abnormalities.
- Used in studies related to aneurysmal subarachnoid hemorrhage
- Used in studies related to cerebral ischemia
- Used in studies related to epilepsy
- Used in studies related to age-related degenerative neurological diseases
- Used in studies related to alcohol intoxication
Medchemexpress LLC (R)-Nimodipine | 77940-92-2 | 99.9% | 1 MG
(R)-Nimodipine | 77940-92-2 | 99.9% | 1 MG
Medchemexpress LLC (S)-Nimodipine | 77940-93-3 | 418.44 | 5 MG
(S)-Nimodipine ((S)-BAY-e 9736) is an enantiomer of Nimodipine. Nimodipine (BAY-e 9736) is an orally active, well-tolerated, and light-sensitive dihydropyridine calcium antagonist. It can be used for the research of cerebrovascular disorders.
- Target: Calcium channel
- Pathway: Membrane transporter/ion channel; neuronal signaling
- Storage (powder): -20°C for 3 years, 4°C for 2 years
- Storage (in solvent): -80°C for 6 months, -20°C for 1 month
- Solubility in vitro: DMSO: 100 mg/mL (238.98 mM; requires ultrasonic)